/

Syncromune

Clinical-stage biopharma developing intratumoral immunotherapies for solid tumors.

BiotechnologyPharmaceuticals syncromune.com ↗

Company facts

Founded: 2020
Employees: 33
Headquarters: United States
Type: Private
Funding: Series A · $145M · 2026